Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "Chairman"

819 News Found

Biocon celebrates 46th Founder’s Day
News | December 04, 2024

Biocon celebrates 46th Founder’s Day

The celebrations began with the unveiling of the Biocon Anthem


Granules' net zero commitment approved by SBTi
News | November 28, 2024

Granules' net zero commitment approved by SBTi

In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030


CAHO and Orchid Pharma partnership kicks off with conference on antimicrobial resistance
Healthcare | November 26, 2024

CAHO and Orchid Pharma partnership kicks off with conference on antimicrobial resistance

This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions


Surendralal Karsanbhai elected to Merck Board of Directors
People | November 25, 2024

Surendralal Karsanbhai elected to Merck Board of Directors

With the addition of Karsanbhai, the Merck board will consist of 13 members


Merck Life Science India ink MoU with GeNext Genomics
Biotech | November 22, 2024

Merck Life Science India ink MoU with GeNext Genomics

Genext Genomics can now offer comprehensive solutions that support the growth of India’s biotech ecosystem


Pfizer appoints Chris Boshoff as Chief Scientific Officer and President, Research & Development
People | November 21, 2024

Pfizer appoints Chris Boshoff as Chief Scientific Officer and President, Research & Development

Roger Dansey to become Interim Chief Oncology Officer and Johanna Bendell to join Pfizer as Oncology Chief Development Officer


Indegene announces new Center in Hyderabad
Digitisation | November 20, 2024

Indegene announces new Center in Hyderabad

With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies


Zota Health Care Q2 FY25 revenue up 48.6%
News | November 16, 2024

Zota Health Care Q2 FY25 revenue up 48.6%

Gross Profit stood at Rs. 36.02 crore compared to Rs. 20.42 crore during Q2FY24, a significant increase of 76.40%


NABH integrates FOGSI’S maternal health standards across its certification programs
News | November 15, 2024

NABH integrates FOGSI’S maternal health standards across its certification programs

The MoU signed in 2022 has progressed and culminated in the subsumption of FOGSI-led Manyata initiative’s 20 quality standards across NABH’s Certification programs


Suven Pharmaceuticals Q2 FY25 revenue grows 12% in Q2
News | November 13, 2024

Suven Pharmaceuticals Q2 FY25 revenue grows 12% in Q2

Pharma CDMO business has posted a 40% YoY in Q2 driven by BD efforts and backed by macro tailwinds